Cargando…
Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
BACKGROUND: Hepatic fibrosis is a dynamic process which ultimately leads to cirrhosis in almost patients with chronic hepatic injury. However, progressive fibrosis is a reversible scarring response. Activation of hepatic stellate cells (HSCs) is the prevailing process during hepatic fibrosis. Osthol...
Autores principales: | Liu, Ya-Wei, Chiu, Yung-Tsung, Fu, Shu-Ling, Huang, Yi-Tsau |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522080/ https://www.ncbi.nlm.nih.gov/pubmed/26231226 http://dx.doi.org/10.1186/s12929-015-0168-5 |
Ejemplares similares
-
Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells
por: Chong, Lee-Won, et al.
Publicado: (2015) -
Inhibitory Effect of Tanshinone IIA on Rat Hepatic Stellate Cells
por: Liu, Ya-Wei, et al.
Publicado: (2014) -
Inhibitory effects of armepavine against hepatic fibrosis in rats
por: Weng, Ting-Chun, et al.
Publicado: (2009) -
Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013) -
Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation
por: Guo, Ren, et al.
Publicado: (2022)